Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | PLCG2 |
| Upstream (Parents) |
|---|
| (<<) ARHGAP25 → PLCG2 |
| (<<) ATIC → PLCG2 |
| (<<) CEBPD → PLCG2 |
| (<<) E2F5 → PLCG2 |
| (<<) HSD17B2 → PLCG2 |
| (<<) IGFBP3 → PLCG2 |
| (<<) IL1R1 → PLCG2 |
| (<<) KLF11 → PLCG2 |
| (<<) MAPKAPK5 → PLCG2 |
| (<<) NR3C1 → PLCG2 |
| (<<) RXRA → PLCG2 |
| (<<) SET → PLCG2 |
| (<<) ST3GAL1 → PLCG2 |
| (<<) STAT4 → PLCG2 |
| Downstream (Children) |
|---|
| PLCG2 → BCL6 (>>) |
| PLCG2 → CASP6 (>>) |
| PLCG2 → CCDC88A (>>) |
| PLCG2 → CD3EAP (>>) |
| PLCG2 → CHST7 (>>) |
| PLCG2 → CKB (>>) |
| PLCG2 → CSTA (>>) |
| PLCG2 → EIF6 (>>) |
| PLCG2 → FAS (>>) |
| PLCG2 → GNA11 (>>) |
| PLCG2 → KCNJ5 (>>) |
| PLCG2 → LCP1 (>>) |
| PLCG2 → MKNK1 (>>) |
| PLCG2 → MYO10 (>>) |
| PLCG2 → PIK3CD (>>) |
| PLCG2 → PNPLA3 (>>) |
| PLCG2 → PPRC1 (>>) |
| PLCG2 → PRKCB (>>) |
| PLCG2 → PYGL (>>) |
| PLCG2 → RAB22A (>>) |
| PLCG2 → RRP9 (>>) |
| PLCG2 → SEMA3A (>>) |
| PLCG2 → SGK1 (>>) |
| PLCG2 → SOCS2 (>>) |
| PLCG2 → SOX9 (>>) |
| PLCG2 → SRC (>>) |
| PLCG2 → TCF7L1 (>>) |
| PLCG2 → UBE2L6 (>>) |
| PLCG2 → VANGL1 (>>) |
